Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia

Published:2023-12 Issue: Volume:262 Page:115860
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ko Bongki,Jang Yongsoo,Kim Min Ha,Lam Thai Thi,Seo Hye Kyung,Jeong Pyeonghwa,Choi Munkyung,Kang Keon Wook,Lee So-Deok,Park Jin-Hee,Kim Myungjin,Han Sun-Young,Kim Yong-Chul^ORCID

Funder

National Research Foundation of Korea

Ministry of Science ICT and Future Planning

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference27 articles.

1. Targeting FLT3 mutations in AML: review of current knowledge and evidence;Daver;Leukemia,2019

2. Acute myeloid leukemia: a comprehensive review and 2016 update;De Kouchkovsky;Blood Cancer J.,2016

3. Acute myeloid leukemia: current progress and future directions;Kantarjian;Blood Cancer J.,2021

4. New therapeutic strategies for adult acute myeloid leukemia;Ishii;Cancers,2022

5. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N. Engl. J. Med.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP